Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Samsung Electronics Co Ltd (005930) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011033
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, HHP, network system, computer, and digital camera. It also manufactures LCD and LED panels, mobile phones and smartphones, tablets, and related accessories. Samsung provides a wide range of solutions for various sectors such as hospitality, healthcare institutions, finance, education, government and insurance. The company operates in the Americas, Europe, Africa, the Middle East and Asia-Pacific through its subsidiaries and affiliates. Samsung is headquartered in Seoul, South Korea.

Samsung Electronics Co Ltd (005930) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Samsung Electronics Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Samsung Electronics Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Samsung Electronics Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Samsung Electronics Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Samsung Electronics Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Samsung Electronics Co Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
WellDoc Raises USD22 Million in First Tranche of Series B Financing 11
NeuroLogica Raises US$12 Million In Series D Financing 12
Partnerships 13
Samsung Electronics Partners with American Cancer Society and Breezie 13
Samsung Electronics Enters into Co-Development Agreement with Mybitat 14
Partners HealthCare Enters into Co-Development Agreement with Samsung Electronics 15
Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 16
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 17
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 18
AirStrip Enters Into Co-Development Agreement With Samsung Electronics For AirStrip One Mobility Software 19
Pathfinder Therapeutics Enters Into Technology Integration Agreement With NeuroLogica 20
Steris Enters Into Technology Integration Agreement With NeuroLogica For Intraoperative Surgical Suites 21
ActiViews Enters Into Agreement With NeuroLogica To Develop Surgical Navigation System 22
NeuroLogica Enters Into Technology Integration Agreement With Medtronic 23
NeuroLogica Enters Into Technology Integration Agreement With BrainLAB 24
NeuroLogica Enters Into Co-Development Agreement With Stryker 25
Schiller Healthcare India Enters Into Distribution Agreement With NeuroLogica 26
Asset Transactions 27
University of Wisconsin Carbone Cancer Center Acquires BodyTom Technology from NeuroLogica 27
Acquisition 28
Samsung Electronics America Acquires NeuroLogica, Medical Imaging Company 28
Samsung Electronics Completes Acquisition Of Nexus Dx From ITC Nexus 29
Samsung Electronics Plans To Acquire Makers Of MRI Scanners And X-Ray Machines 30
Samsung Electronics Acquires 65.8% Stake In Medison 31
Samsung Completes Acquisition Of Prosonic From Consus Asset Management For US$38 Million 32
Samsung Electronics Co Ltd – Key Competitors 33
Samsung Electronics Co Ltd – Key Employees 34
Samsung Electronics Co Ltd – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Samsung Electronics Co Ltd, Medical Equipment, Key Facts, 2016 2
Samsung Electronics Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Samsung Electronics Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Samsung Electronics Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Samsung Electronics Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Samsung Electronics Co Ltd, Deals By Market, 2011 to YTD 2017 8
Samsung Electronics Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
WellDoc Raises USD22 Million in First Tranche of Series B Financing 11
NeuroLogica Raises US$12 Million In Series D Financing 12
Samsung Electronics Partners with American Cancer Society and Breezie 13
Samsung Electronics Enters into Co-Development Agreement with Mybitat 14
Partners HealthCare Enters into Co-Development Agreement with Samsung Electronics 15
Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 16
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 17
Cigna And Samsung Electronics Enter Into Agreement To Provide Health Improvement Platform 18
AirStrip Enters Into Co-Development Agreement With Samsung Electronics For AirStrip One Mobility Software 19
Pathfinder Therapeutics Enters Into Technology Integration Agreement With NeuroLogica 20
Steris Enters Into Technology Integration Agreement With NeuroLogica For Intraoperative Surgical Suites 21
ActiViews Enters Into Agreement With NeuroLogica To Develop Surgical Navigation System 22
NeuroLogica Enters Into Technology Integration Agreement With Medtronic 23
NeuroLogica Enters Into Technology Integration Agreement With BrainLAB 24
NeuroLogica Enters Into Co-Development Agreement With Stryker 25
Schiller Healthcare India Enters Into Distribution Agreement With NeuroLogica 26
University of Wisconsin Carbone Cancer Center Acquires BodyTom Technology from NeuroLogica 27
Samsung Electronics America Acquires NeuroLogica, Medical Imaging Company 28
Samsung Electronics Completes Acquisition Of Nexus Dx From ITC Nexus 29
Samsung Electronics Plans To Acquire Makers Of MRI Scanners And X-Ray Machines 30
Samsung Electronics Acquires 65.8% Stake In Medison 31
Samsung Completes Acquisition Of Prosonic From Consus Asset Management For US$38 Million 32
Samsung Electronics Co Ltd, Key Competitors 33
Samsung Electronics Co Ltd, Key Employees 34
Samsung Electronics Co Ltd, Other Locations 35
Samsung Electronics Co Ltd, Subsidiaries 36
Samsung Electronics Co Ltd, Joint Venture 38

★海外企業調査レポート[Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invuity Inc (IVTY)-医療機器分野:企業M&A・提携分析
    Summary Invuity Inc (Invuity) is a medical technology company that offers visualization products for the less invasive surgical procedures. The company offers handhelds, retractors and drop-ins. Its handhelds products include saber frazier and saber yankauer. Invuity offers retractors such as breite …
  • BSN medical GmbH:企業の戦略的SWOT分析
    BSN medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Morphotek Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases. Its pipeline product portfolio includes farletuzumab …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務分析
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AcelRx Pharmaceuticals Inc (ACRX):製薬・医療:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Lincoln National Corporation:戦略・SWOT・企業財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Greentech Energy Systems AS (GES)-エネルギー分野:企業M&A・提携分析
    Summary Greentech Energy Systems AS (Greentech) is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Greentech expands its asset portfolio through inorganic growt …
  • OHB SE:企業の戦略・SWOT・財務情報
    OHB SE - Strategy, SWOT and Corporate Finance Report Summary OHB SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • Commonwealth Bank of Australia:企業のM&A・事業提携・投資動向
    Commonwealth Bank of Australia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Commonwealth Bank of Australia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Korea Development Bank:企業の戦略・SWOT・財務情報
    Korea Development Bank - Strategy, SWOT and Corporate Finance Report Summary Korea Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wellcome Trust Sanger Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Karolinska Development AB (KDEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Windtree Therapeutics Inc (WINTD):企業の財務・戦略的SWOT分析
    Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • NightstaRx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NightstaRx Ltd (NightstaRx) a subsidiary of Nightstar Therapeutics PLC is a clinical-stage gene therapy company that engaged in developing and commercializing novel. The company also involved in providing one-time treatments for patients suffering from rare inherited retinal diseases. It pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆